Accumulation of Non-steroidal Anti-inflammatory Drugs by Gingival Fibroblasts

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) are used to manage pain and inflammatory disorders. We hypothesized that gingival fibroblasts actively accumulate NSAIDs and enhance their levels in gingival connective tissue. Using fluorescence to monitor NSAID transport, we demonstrated that cultured gingival fibroblasts transport naproxen in a saturable, temperature-dependent manner with a K_m of 127 μg/mL and a V_max of 1.42 ng/min/μg protein. At steady state, the intracellular/extracellular concentration ratio was 1.9 for naproxen and 7.2 for ibuprofen. Naproxen transport was most efficient at neutral pH and was significantly enhanced upon cell treatment with TNF-α. In humans, systemically administered naproxen attained steady-state levels of 61.9 μg/mL in blood and 9.4 μg/g in healthy gingival connective tissue, while ibuprofen attained levels of 2.3 μg/mL and 1.5 μg/g, respectively. Thus, gingival fibroblasts possess transporters for NSAIDs that are up-regulated by an inflammatory mediator, but there is no evidence that they contribute to elevated NSAID levels in healthy gingiva.

Get full access to this article

View all access options for this article.

References

Birkedal-Hansen H (1993). Role of cytokines and inflammatory mediators in tissue destruction. J Periodontal Res 28(6 Pt 2):500–510.

Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Anal Biochem 72:248–254.

Cushman DW, Cheung HS (1976). Effect of substrate concentration on inhibition of prostaglandin synthetase of bull seminal vesicles by anti-inflammatory drugs and fenamic acid analogs. Biochim Biophys Acta 424:449–459.

Dominkus M, Nicolakis M, Kotz R, Wilkinson FE, Kaiser RR, Chlud K (1996). Comparison of tissue and plasma levels of ibuprofen after oral and topical administration. Arzneimittelforschung 46:1138–1143.

Farrar H, Letzig L, Gill M (2002). Validation of a liquid chromatographic method for the determination of ibuprofen in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 780:341–348.

Gorospe M, Kumar S, Baglioni C (1993). Tumor necrosis factor increases stability of interleukin-1 mRNA by activating protein kinase C. J Biol Chem 268:6214–6220.

Jeffcoat MK, Reddy MS, Haigh S, Buchanan W, Doyle MJ, Meredith MP, et al. (1995). A comparison of topical ketorolac, systemic flurbiprofen, and placebo for the inhibition of bone loss in adult periodontitis. J Periodontol 66:329–338.

Lavda M, Clausnitzer CE, Walters JD (2004). Distribution of systemic ciprofloxacin and doxycycline to gingiva and gingival crevicular fluid. J Periodontol 75:1663–1667.

Lin JH, Cocchetto DM, Duggan DE (1987). Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs. Clin Pharmacokinet 12:402–432.

10.

Lindhe J, Karring T, Araujo M (2003). Anatomy of the periodontium. In: Clinical periodontology and implant dentistry. Lindhe J, Karring T, Lang NP, editors. Oxford: Blackwell Munksgaard, pp. 3–49.

11.

Mariotti A, Cochran DL (1990). Characterization of fibroblasts derived from human periodontal ligament and gingiva. J Periodontol 61:103–111.

12.

O’Brien TP, Roszkowski MT, Wolff LF, Hinrichs JE, Hargreaves KM (1996). Effect of a non-steroidal anti-inflammatory drug on tissue levels of immunoreactive prostaglandin E2, immunoreactive leukotriene, and pain after periodontal surgery. J Periodontol 67:1307–1316.

13.

Offenbacher S, Odle BM, Van Dyke TE (1986). The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss. J Periodontal Res 21:101–112.

14.

Offenbacher S, Williams RC, Jeffcoat MK, Howell TH, Odle BM, Smith MA, et al. (1992). Effects of NSAIDs on beagle crevicular cyclooxygenase metabolites and periodontal bone loss. J Periodontal Res 27:207–213.

15.

Offenbacher S, Heasman PA, Collins JG (1993). Modulation of host PGE2 secretion as a determinant of periodontal disease expression. J Periodontol 64(5 Suppl):432–444.

16.

Roelofsen H, Ottenhoff R, Oude Elferink RP, Jansen PL (1991). Hepatocanalicular organic-anion transport is regulated by protein kinase C. Biochem J 278(Pt 3):637–641.

17.

Sadecka J, Cakrt M, Hercegova A, Polonsky J, Skacani I (2001). Determination of ibuprofen and naproxen in tablets. J Pharm Biomed Anal 25:881–891.

18.

Schroeder HE, Munzel-Pedrazzoli S, Page R (1973). Correlated morphometric and biochemical analysis of gingival tissue in early chronic gingivitis in man. Arch Oral Biol 18:899–923.

19.

Walters JD, Nakkula RJ, Maney P (2005). Modulation of gingival fibroblast minocycline accumulation by biological mediators. J Dent Res 84:320–323.

20.

Williams RC, Jeffcoat MK, Kaplan ML, Goldhaber P, Johnson HG, Wechter WJ (1985). Flurbiprofen: a potent inhibitor of alveolar bone resorption in beagles. Science 227:640–642.

21.

Williams RC, Jeffcoat MK, Howell TH, Rolla A, Stubbs D, Teoh KW, et al. (1989). Altering the progression of human alveolar bone loss with the non-steroidal anti-inflammatory drug flurbiprofen. J Periodontol 60:485–490.

22.

Yang Q, Nakkula RJ, Walters JD (2002). Accumulation of ciprofloxacin and minocycline by cultured human gingival fibroblasts. J Dent Res 81:836–840.

23.

You G (2004). Towards an understanding of organic anion transporters: structure-function relationships. Med Res Rev 24:762–774.